IXC 1.35% 7.5¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-142

  1. 795 Posts.
    lightbulb Created with Sketch. 45
    $1.30 yeah and I believe he was the largest participant in that round
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.